Sources | Names Used |
---|---|
CTRPv2 | selumetinib:decitabine (4:1 mol/mol) |
PharmacoGx | selumetinib:decitabine (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | EPDR1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | ORAI3 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |
mRNA | TM9SF1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
mRNA | B4GALT4 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.01 |
mRNA | MRPS25 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | TRIM51 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
mRNA | IL16 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
mRNA | WNK1 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | HYKK | CTRPv2 | pan-cancer | AAC | -0.087 | 0.01 |
mRNA | LPCAT2 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.01 |